Literature DB >> 26005632

Management of gastrointestinal involvement in scleroderma.

Vivek Nagaraja1, Zsuzsanna H McMahan2, Terri Getzug1, Dinesh Khanna3.   

Abstract

Gastrointestinal tract (GIT) commonly affects patients with systemic sclerosis (SSc). The GI involvement is quite heterogeneous varying from asymptomatic disease to significant dysmotility causing complications like malabsorption, weight loss and severe malnutrition. This review focuses on the management of GI involvement in SSc and has been categorized based on the segment of GIT involved. A brief discussion on the role of patient reported outcome measures in SSc-GI involvement has also been incorporated.

Entities:  

Keywords:  Gastrointestinal tract; bacterial overgrowth; constipation; diarrhea; dysphagia; gastric antral vascular ectasia; gastroesophageal reflux; gastroparesis; intestinal dysmotility; nutrition; scleroderma; systemic sclerosis

Year:  2015        PMID： 26005632      PMCID： PMC4437639          DOI： 10.1007/s40674-014-0005-0

Source DB:  PubMed          Journal:  Curr Treatm Opt Rheumatol        ISSN： 2198-6002


  140 in total

1.  Disease-related malnutrition in outpatients with systemic sclerosis.

Authors:  Roberto Caporali; Riccardo Caccialanza; Claudia Bonino; Catherine Klersy; Emanuele Cereda; Blerina Xoxi; Anna Crippa; Maria Luisa Rava; Margherita Orlandi; Chiara Bonardi; Barbara Cameletti; Veronica Codullo; Carlomaurizio Montecucco
Journal:  Clin Nutr       Date:  2012-03-13       Impact factor: 7.324

Review 2.  Gastric antral vascular ectasia (GAVE): an update on clinical presentation, pathophysiology and treatment.

Authors:  Christian P Selinger; Yeng S Ang
Journal:  Digestion       Date:  2008-04-04       Impact factor: 3.216

3.  Esophageal involvement and pulmonary manifestations in systemic sclerosis.

Authors:  I Marie; S Dominique; H Levesque; P Ducrotté; P Denis; M F Hellot; H Courtois
Journal:  Arthritis Rheum       Date:  2001-08

4.  Efficacy of prolonged administration of intravenous erythromycin in an ambulatory setting as treatment of severe gastroparesis: one center's experience.

Authors:  J K DiBaise; E M Quigley
Journal:  J Clin Gastroenterol       Date:  1999-03       Impact factor: 3.062

5.  Early endoscopy in systemic sclerosis without gastrointestinal symptoms.

Authors:  Rene Thonhofer; Cornelia Siegel; Markus Trummer; Winfried Graninger
Journal:  Rheumatol Int       Date:  2010-08-14       Impact factor: 2.631

6.  Treatment of gastric antral vascular ectasia (watermelon stomach) with endoscopic band ligation.

Authors:  Christopher D Wells; M Edwyn Harrison; Suryakanth R Gurudu; Michael D Crowell; Thomas J Byrne; Giovanni Depetris; Virender K Sharma
Journal:  Gastrointest Endosc       Date:  2008-06-03       Impact factor: 9.427

Review 7.  Systematic review: pathophysiology and management of gastrointestinal dysmotility in systemic sclerosis (scleroderma).

Authors:  H Sallam; T A McNearney; J D Z Chen
Journal:  Aliment Pharmacol Ther       Date:  2006-03-15       Impact factor: 8.171

8.  Construct validity of the Patient-Reported Outcomes Measurement Information System gastrointestinal symptom scales in systemic sclerosis.

Authors:  Vivek Nagaraja; Ron D Hays; Puja P Khanna; Brennan M R Spiegel; Lin Chang; Gil Y Melmed; Roger Bolus; Dinesh Khanna
Journal:  Arthritis Care Res (Hoboken)       Date:  2014-11       Impact factor: 4.794

9.  The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders.

Authors:  L Ganzini; D E Casey; W F Hoffman; A L McCall
Journal:  Arch Intern Med       Date:  1993-06-28

Review 10.  Gastrointestinal manifestations of systemic sclerosis.

Authors:  Robyn Domsic; Kenneth Fasanella; Klaus Bielefeldt
Journal:  Dig Dis Sci       Date:  2007-10-13       Impact factor: 3.199
View more
  20 in total

1.  Successful treatment of prokinetic-resistant intestinal pseudo-obstruction and pneumatosis cystoides intestinalis in systemic sclerosis with metronidazole.

Authors:  Masaaki Fujita; Yumiko Nakano; Masato Yagita
Journal:  Rheumatol Int       Date:  2017-02-17       Impact factor: 2.631

Review 2.  Gastrointestinal and Hepatic Disease in Systemic Sclerosis.

Authors:  Tracy M Frech; Diane Mar
Journal:  Rheum Dis Clin North Am       Date:  2018-02       Impact factor: 2.670

Review 3.  Intestinal Involvement in Systemic Sclerosis: A Clinical Review.

Authors:  Lazaros I Sakkas; Theodora Simopoulou; Dimitrios Daoussis; Stamatis-Nick Liossis; Spyros Potamianos
Journal:  Dig Dis Sci       Date:  2018-02-21       Impact factor: 3.199

4.  Gastrointestinal involvement in systemic sclerosis: Effects on morbidity and mortality and new therapeutic approaches.

Authors:  Anna-Maria Hoffmann-Vold; Elizabeth R Volkmann
Journal:  J Scleroderma Relat Disord       Date:  2019-12-20

5.  Use of vonoprazan, a novel potassium-competitive acid blocker, for the treatment of proton pump inhibitor-refractory reflux esophagitis in patients with systemic sclerosis.

Authors:  Yuichiro Shirai; Noriyuki Kawami; Katsuhiko Iwakiri; Masataka Kuwana
Journal:  J Scleroderma Relat Disord       Date:  2021-06-07

6.  Abnormal esophageal acid exposure on high-dose proton pump inhibitor therapy is common in systemic sclerosis patients.

Authors:  E K Stern; D A Carlson; S Falmagne; A D Hoffmann; M Carns; J E Pandolfino; M Hinchcliff; D M Brenner
Journal:  Neurogastroenterol Motil       Date:  2017-11-06       Impact factor: 3.598

Review 7.  GI Manifestations With a Focus on the Esophagus: Recent Progress in Understanding Pathogenesis.

Authors:  Marie-Pier Tétreault; Peter Kahrilas
Journal:  Curr Rheumatol Rep       Date:  2019-07-03       Impact factor: 4.592

8.  Relationship Between Gastrointestinal Transit, Medsger Gastrointestinal Severity, and University of California-Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract 2.0 Symptoms in Patients With Systemic Sclerosis.

Authors:  Zsuzsanna H McMahan; Ana E Tucker; Jamie Perin; Elizabeth R Volkmann; Subhash Kulkarni; Harvey A Ziessman; Pankaj J Pasricha; Fredrick M Wigley
Journal:  Arthritis Care Res (Hoboken)       Date:  2022-01-25       Impact factor: 4.794

9.  Managing gastrointestinal complications in patients with systemic sclerosis.

Authors:  Z H McMahan; D Khanna
Journal:  Curr Treat Options Gastroenterol       Date:  2020-11-13

Review 10.  Esophageal manifestation in patients with scleroderma.

Authors:  Theodoros A Voulgaris; Georgios P Karamanolis
Journal:  World J Clin Cases       Date:  2021-07-16       Impact factor: 1.337
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.